Results 131 to 140 of about 315,809 (313)

Autoimmune and paraneoplastic encephalitis–associated neuronal autoantibodies with serial EEG in adults with unexplained new‐onset seizures or worsening epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Unexplained seizures or worsening epilepsy in adult patients may be associated with specific neuronal or onconeuronal antibodies. We propose that comprehensive antibody testing is beneficial for adults with new‐onset seizures or aggravated epilepsy without a predetermined etiology.
Chang‐Yu Edward Cheng   +5 more
wiley   +1 more source

Late‐onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi‐center prospective longitudinal observational study (ELUCID)

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam   +13 more
wiley   +1 more source

Case report: Distinct neurologic manifestation and cytokine profile of a child with COVID-19-associated acute fulminant encephalitis [PDF]

open access: gold, 2023
Yu-Ming Chang   +5 more
openalex   +1 more source

Connecting the Dots: Systems Thinking Highlights the Role of the Environment Sector in One Health Operationalization

open access: yesGlobal Challenges, EarlyView.
This perspective highlights the need for a systems thinking approach in One Health to holistically address zoonotic disease prevention, and to strengthen connections with the environment sector for global pandemic preparedness. Abstract With One Health (OH) encompassing a holistic view of the interrelated health of humans, animals and environment ...
Alana Hansen   +3 more
wiley   +1 more source

The causal relationship between systemic lupus erythematosus and juvenile myoclonic epilepsy: A Mendelian randomization study and mediation analysis

open access: yesIbrain, Volume 11, Issue 1, Page 98-105, Spring 2025.
Mendelian randomization (MR) studies were conducted using the inverse‐variance weighted (IVW) method, MR‐Egger and weighted median on juvenile myoclonic epilepsy (JME), and systemic lupus erythematosus (SLE) data from the Integrative Epidemiology Unit (IEU) Open genome‐wide association study (GWAS) database and the International League Against Epilepsy
Sirui Chen   +10 more
wiley   +1 more source

Molecular Organization of a Recombinant Subviral Particle from Tick-Borne Encephalitis Virus [PDF]

open access: bronze, 2001
Ilaria Ferlenghi   +8 more
openalex   +1 more source

Anti‐NMDA receptor autoimmune encephalitis associated with ovarian teratoma: A case series and literature review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 23-30, April 2025.
Abstract Autoimmune encephalitis is a group of disorders characterized by symptoms of dysfunction of the limbic and extra‐limbic systems that occur in association with antibodies against intracellular antigens, synapses, or proteins located on the surface of nerve cells. Anti‐NMDA (N‐methyl‐D‐aspartate) receptor encephalitis was first described in 2007
Pham Ba Nha   +6 more
wiley   +1 more source

Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review

open access: diamond, 2017
Kiyomi Mashima   +17 more
openalex   +2 more sources

Antibody-mediated encephalitis: a treatable cause of schizophrenia [PDF]

open access: bronze, 2012
Belinda Lennox   +2 more
openalex   +1 more source

Correction to: Refractory anti‑NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review [PDF]

open access: bronze, 2021
Serena Marita Lazzarin   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy